CH632738A5 - Peptide mit gonadoliberin-wirkung und verfahren zu ihrer herstellung. - Google Patents

Peptide mit gonadoliberin-wirkung und verfahren zu ihrer herstellung. Download PDF

Info

Publication number
CH632738A5
CH632738A5 CH482277A CH482277A CH632738A5 CH 632738 A5 CH632738 A5 CH 632738A5 CH 482277 A CH482277 A CH 482277A CH 482277 A CH482277 A CH 482277A CH 632738 A5 CH632738 A5 CH 632738A5
Authority
CH
Switzerland
Prior art keywords
ser
arg
pro
leu
tyr
Prior art date
Application number
CH482277A
Other languages
German (de)
English (en)
Inventor
Wolfgang Dr Koenig
Rolf Dr Geiger
Juergen Dr Sandow
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of CH632738A5 publication Critical patent/CH632738A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/23—Luteinising hormone-releasing hormone [LHRH]; Related peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/13—Luteinizing hormone-releasing hormone; related peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
CH482277A 1976-04-22 1977-04-19 Peptide mit gonadoliberin-wirkung und verfahren zu ihrer herstellung. CH632738A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE2617646A DE2617646C2 (de) 1976-04-22 1976-04-22 Nonapeptid-amide und Decapeptid-amide mit Gonadoliberin-Wirkung, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate

Publications (1)

Publication Number Publication Date
CH632738A5 true CH632738A5 (de) 1982-10-29

Family

ID=5975965

Family Applications (1)

Application Number Title Priority Date Filing Date
CH482277A CH632738A5 (de) 1976-04-22 1977-04-19 Peptide mit gonadoliberin-wirkung und verfahren zu ihrer herstellung.

Country Status (15)

Country Link
US (1) US4118483A (cg-RX-API-DMAC7.html)
JP (1) JPS52131578A (cg-RX-API-DMAC7.html)
AT (1) AT353992B (cg-RX-API-DMAC7.html)
AU (1) AU509608B2 (cg-RX-API-DMAC7.html)
BE (1) BE853887A (cg-RX-API-DMAC7.html)
CA (1) CA1099703A (cg-RX-API-DMAC7.html)
CH (1) CH632738A5 (cg-RX-API-DMAC7.html)
DE (1) DE2617646C2 (cg-RX-API-DMAC7.html)
DK (1) DK175177A (cg-RX-API-DMAC7.html)
FR (1) FR2348913A1 (cg-RX-API-DMAC7.html)
GB (1) GB1572126A (cg-RX-API-DMAC7.html)
IL (1) IL51924A (cg-RX-API-DMAC7.html)
IT (1) IT1075743B (cg-RX-API-DMAC7.html)
NL (1) NL7704150A (cg-RX-API-DMAC7.html)
SE (1) SE7704543L (cg-RX-API-DMAC7.html)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2735515A1 (de) * 1977-08-06 1979-02-22 Hoechst Ag Verwendung von lh-rh-peptiden als antikonzeptive
US4244946A (en) * 1979-06-11 1981-01-13 The Salk Institute For Biological Studies Water-soluble peptides affecting gonadal function
US4234571A (en) * 1979-06-11 1980-11-18 Syntex (U.S.A.) Inc. Nonapeptide and decapeptide derivatives of luteinizing hormone releasing hormone
IT1149971B (it) * 1979-06-11 1986-12-10 Syntex Inc Derivati nonapeptide e decapeptide dell'ormone che rilascia l'ormone luteinizzante
US4256737A (en) * 1979-06-11 1981-03-17 Syntex (U.S.A.) Inc. Long acting depot injectable formulations for LH-RH analogues
US4377515A (en) * 1979-10-01 1983-03-22 Merck & Co., Inc. Long lasting agonists and antagonists of LH-RH
US4301066A (en) * 1980-05-08 1981-11-17 American Home Products Corp. Preparation of (D-Trp 6)-LH-RH via the heptapeptide H-Ser-Tyr-D-Trp-Leu-Arg-Pro-Gly-NH2
DE3020941A1 (de) * 1980-06-03 1981-12-17 Hoechst Ag, 6000 Frankfurt Nonapeptid, verfahren zu seiner herstellung, dieses enthaltendes mittel und seine verwendung
US4444759A (en) * 1982-07-26 1984-04-24 The Salk Institute For Biological Studies GnRH Antagonists II
US4443368A (en) * 1982-11-01 1984-04-17 The Salk Institute For Biological Studies Peptides affecting gonadal function
US4410514A (en) * 1982-12-06 1983-10-18 The Salk Institute For Biological Studies GnRH Agonists
US5116817A (en) * 1982-12-10 1992-05-26 Syntex (U.S.A.) Inc. LHRH preparations for intranasal administration
HU187503B (en) * 1983-03-29 1986-01-28 Magyar Tudomanyos Akademia,Hu Process for preparing gonadoliberine derivatives containing beta-aspartyl group
US4605643A (en) * 1984-03-02 1986-08-12 The Salk Institute For Biological Studies Ovine GRF
IT1178775B (it) * 1983-12-23 1987-09-16 Konzponti Valto Es Hitelbank R Derivati della gonadoliberina e procedimento per la loro preparazione
HU189394B (en) * 1983-12-23 1986-06-30 Koezponti Valto- Es Hitelbank Rt Innovacios Alap,Hu Method for producing spermatozoa suitable for fertilization from mature fishes
DE3414595A1 (de) * 1984-04-18 1985-10-31 Hoechst Ag, 6230 Frankfurt Verwendung von gonadoliberin und gonadoliberinagonisten zur behandlung klimakterischer beschwerden
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
US4760053A (en) * 1984-08-02 1988-07-26 Fernand Labrie Combination therapy for selected sex steroid dependent cancers
US4666885A (en) * 1985-02-08 1987-05-19 Fernand Labrie Combination therapy for treatment of female breast cancer
US4775660A (en) * 1984-08-02 1988-10-04 Fernand Labrie Treatment of breast cancer by combination therapy
US4677193A (en) * 1985-02-22 1987-06-30 The Salk Institute For Biological Studies Peptides containing an aliphatic-aromatic ketone side chain
HU193607B (en) * 1985-07-18 1987-11-30 Innofinance Altalanos Innovaci Process for production of sexual products applyable for natural or artificial insemination for mammates
DE3842010A1 (de) * 1988-12-14 1990-06-21 Hoechst Ag Kompetitive gonadoliberin-antagonisten
DE69022722T2 (de) * 1989-03-10 1996-05-02 Endorecherche Inc., Ste-Foy, Quebec Kombinationstherapie zur behandlung von estrogenempfindlichen erkrankungen.
US5372996A (en) * 1989-03-10 1994-12-13 Endorecherche, Inc. Method of treatment of androgen-related diseases
GR1001164B (el) * 1989-07-07 1993-05-24 Endorecherche Inc Παραγωγα αρρενογονου ορμονης προς χρησιν εις την αναστολην δραστηριοτητος της στεροειδους ορμονης φυλου
WO1991000733A1 (en) * 1989-07-07 1991-01-24 Endorecherche Inc. Method of treatment of androgen-related diseases
WO1993023053A1 (en) * 1992-05-21 1993-11-25 Endorecherche Inc. INHIBITORS OF TESTOSTERONE 5α-REDUCTASE ACTIVITY
IT1264129B1 (it) * 1993-04-09 1996-09-16 Codev S A Peptidi ad attivita' immunomodulatoria derivati da frammenti di leucochinina
US5843901A (en) * 1995-06-07 1998-12-01 Advanced Research & Technology Institute LHRH antagonist peptides
US20040258672A1 (en) * 1999-04-15 2004-12-23 Monash University Graft acceptance through manipulation of thymic regeneration
US20040259803A1 (en) * 1999-04-15 2004-12-23 Monash University Disease prevention by reactivation of the thymus
US20050020524A1 (en) * 1999-04-15 2005-01-27 Monash University Hematopoietic stem cell gene therapy
US20070274946A1 (en) * 1999-04-15 2007-11-29 Norwood Immunoloty, Ltd. Tolerance to Graft Prior to Thymic Reactivation
AUPR074500A0 (en) * 2000-10-13 2000-11-09 Monash University Treatment of t cell disorders
US20040265285A1 (en) * 1999-04-15 2004-12-30 Monash University Normalization of defective T cell responsiveness through manipulation of thymic regeneration
US20040241842A1 (en) * 1999-04-15 2004-12-02 Monash University Stimulation of thymus for vaccination development
US20060088512A1 (en) * 2001-10-15 2006-04-27 Monash University Treatment of T cell disorders
US20080279812A1 (en) * 2003-12-05 2008-11-13 Norwood Immunology, Ltd. Disease Prevention and Vaccination Prior to Thymic Reactivation
KR101731008B1 (ko) 2010-06-16 2017-04-27 앙도르쉐르슈 인코포레이티드 에스트로겐-관련 질병의 치료 또는 예방 방법

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7505590A (nl) * 1974-05-18 1975-11-20 Hoechst Ag Werkwijze voor het bereiden van peptiden met lh-rh/fsh-rh-werking.
DE2438350C3 (de) * 1974-08-09 1979-06-13 Hoechst Ag, 6000 Frankfurt Peptide mit starker LH-RH/FSH-RH-Wirkung, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zubereitungen

Also Published As

Publication number Publication date
JPS52131578A (en) 1977-11-04
NL7704150A (nl) 1977-10-25
IL51924A (en) 1980-06-30
ATA278277A (de) 1979-05-15
IL51924A0 (en) 1977-06-30
JPS6110480B2 (cg-RX-API-DMAC7.html) 1986-03-29
DE2617646C2 (de) 1986-07-31
DE2617646A1 (de) 1977-11-03
IT1075743B (it) 1985-04-22
US4118483A (en) 1978-10-03
AU509608B2 (en) 1980-05-15
DK175177A (da) 1977-10-23
FR2348913B1 (cg-RX-API-DMAC7.html) 1980-02-15
GB1572126A (en) 1980-07-23
SE7704543L (sv) 1977-10-23
AU2447477A (en) 1978-10-26
FR2348913A1 (fr) 1977-11-18
CA1099703A (en) 1981-04-21
BE853887A (fr) 1977-10-24
AT353992B (de) 1979-12-10

Similar Documents

Publication Publication Date Title
CH632738A5 (de) Peptide mit gonadoliberin-wirkung und verfahren zu ihrer herstellung.
US4024248A (en) Peptides having LH-RH/FSH-RH activity
DE2435027C2 (de) Nonapeptidamide und Verfahren zu ihrer Herstellung
DE2321174C2 (de) Nonapeptidamid und Verfahren zu ihrer Herstellung
DE2720245C2 (de) Peptide, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Zusammensetzungen
DE69216150T2 (de) Tachykininderivate, deren Herstellung und diese enthaltende pharmazeutische Zusammensetzungen
EP0019115B1 (de) Pankreozymin-Cholezystokinin aktive Peptide, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel
DE3587016T2 (de) Nona- und dekapeptidanaloga von lhrh, welche als lhrh-antagonisten dienen.
DE2741393C2 (cg-RX-API-DMAC7.html)
EP0026464A2 (de) Peptide, deren Herstellung, deren Verwendung und pharmazeutische Präparate
DE2256445A1 (de) Neue heptapeptide mit gastrinwirkung
CH615904A5 (en) Process for the preparation of L-leucine-13-motilin
DE2726276C2 (de) Luliberin-Antagonisten, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Zusammensetzungen
CH664968A5 (de) Gonadoliberin-derivate und verfahren zu ihrer herstellung.
DE3700166A1 (de) In der 6-stellung einen aromatischen aminocarbonsaeurerest aufweisende nonapeptidaethylamide beziehungsweise decapeptidamide, verfahren zur herstellung derselben und diese enthaltende arzneimittel beziehungsweise vermehrungsbiologisch wirksame mittel sowie ihre verwendung
EP0003028A1 (de) Beta h-Endorphin-Analoge, diese enthaltende Präparate und deren Herstellung
EP0477499B1 (de) Gonadoliberin-Antagonisten
DE68914544T2 (de) Peptid und Wirkstoff gegen Dementia.
AT373232B (de) Verfahren zur herstellung von neuen peptiden
AT365561B (de) Verfahren zur herstellung von neuen peptiden
DE3537405A1 (de) Biologisch aktive penta- und heptapeptide, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE3842010A1 (de) Kompetitive gonadoliberin-antagonisten
DE2460333A1 (de) Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
DE2424287A1 (de) Peptide mit lh-rh/fsh-rh-wirkung und verfahren zu ihrer herstellung
DD139125B1 (de) Verfahren zur herstellung von undekapeptiden

Legal Events

Date Code Title Description
PL Patent ceased
PL Patent ceased